140 related articles for article (PubMed ID: 1979305)
1. Ha-ras-1 alleles in Norwegian lung cancer patients.
Ryberg D; Tefre T; Ovrebø S; Skaug V; Stangeland L; Naalsund A; Baera R; Børresen AL; Haugen A
Hum Genet; 1990 Nov; 86(1):40-4. PubMed ID: 1979305
[TBL] [Abstract][Full Text] [Related]
2. Allele diversity of the H-ras-1 variable number of tandem repeats in Norwegian lung cancer patients.
Ryberg D; Tefre T; Skaug V; Stangeland L; Ovrebø S; Naalsund A; Børresen AL; Haugen A
Environ Health Perspect; 1992 Nov; 98():187-9. PubMed ID: 1362538
[TBL] [Abstract][Full Text] [Related]
3. Distribution and rearrangements of alleles of c-Ha-ras-1 protooncogene and their correlation with the development of lung, ovarian and thyroid cancers.
Knyazev PG; Nikiforova IF; Serova OM; Pluzhnikova GF
Neoplasma; 1990; 37(6):647-55. PubMed ID: 1980342
[TBL] [Abstract][Full Text] [Related]
4. Rare Ha-ras1 alleles and predisposition to testicular cancer.
Ryberg D; Heimdal K; Fosså SD; Børresen AL; Haugen A
Int J Cancer; 1993 Apr; 53(6):938-40. PubMed ID: 8097187
[TBL] [Abstract][Full Text] [Related]
5. [Restriction polymorphism of the proto-oncogene c-Ha-ras-1 in patients with multiple primary malignant neoplasms and non-small-cell lung cancer].
Gaspar'ian AV; Sel'chuk VIu; Iakubovskaia MG; Zborovskaia IB; Tatosian AG
Genetika; 1997 Jan; 33(1):96-100. PubMed ID: 9162692
[TBL] [Abstract][Full Text] [Related]
6. Ha-ras polymorphisms in epithelial ovarian cancer.
O'Briant K; Chrysson N; Hunter V; Tyson F; Tanner M; Daly L; George SL; Berchuck A; Soper J; Fowler W
Gynecol Oncol; 1992 Jun; 45(3):299-302. PubMed ID: 1351862
[TBL] [Abstract][Full Text] [Related]
7. Racial variation in the distribution of Ha-ras-1 alleles.
Weston A; Vineis P; Caporaso NE; Krontiris TG; Lonergan JA; Sugimura H
Mol Carcinog; 1991; 4(4):265-8. PubMed ID: 1714739
[TBL] [Abstract][Full Text] [Related]
8. Increased frequency of specific alleles of the c-Ha-ras gene in Japanese cancer patients.
Honda K; Ishizaki K; Ikenaga M; Toguchida J; Inamoto T; Tanaka K; Ozawa K
Hum Genet; 1988 Aug; 79(4):297-300. PubMed ID: 2900800
[TBL] [Abstract][Full Text] [Related]
9. Association of rare alleles of the Harvey ras protooncogene locus with lung cancer.
Sugimura H; Caporaso NE; Modali RV; Hoover RN; Resau JH; Trump BF; Longergan JA; Krontiris TG; Mann DL; Weston A
Cancer Res; 1990 Mar; 50(6):1857-62. PubMed ID: 2407346
[TBL] [Abstract][Full Text] [Related]
10. Ha-ras restriction fragment length polymorphisms in colorectal cancer.
Wyllie FS; Wynford-Thomas V; Lemoine NR; Williams GT; Williams ED; Wynford-Thomas D
Br J Cancer; 1988 Feb; 57(2):135-8. PubMed ID: 2896015
[TBL] [Abstract][Full Text] [Related]
11. H-ras-1 restriction fragment length polymorphism in normal individuals and oral cancer patients in India.
Bhoite LT; Saranath D; Nair R; Deo MG; Sanghavi V; Mehta A
J Oral Pathol Med; 1993 Aug; 22(7):298-302. PubMed ID: 7901404
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of CCGG sites in the 3' region of H-ras protooncogene is frequent and is associated with H-ras allele loss in non-small cell lung cancer.
Vachtenheim J; Horáková I; Novotná H
Cancer Res; 1994 Mar; 54(5):1145-8. PubMed ID: 8118795
[TBL] [Abstract][Full Text] [Related]
13. c-Ha-ras polymorphism in patients with hepatocellular carcinoma. Comparison of healthy subjects and alcoholic patients with cirrhosis.
Thelu MA; Zarski JP; Froissart B; Rachail M; Seigneurin JM
Gastroenterol Clin Biol; 1993; 17(12):903-7. PubMed ID: 7907302
[TBL] [Abstract][Full Text] [Related]
14. Lack of correlation between rare Ha-ras alleles and urothelial cancer in Japan.
Ishikawa J; Maeda S; Takahashi R; Kamidono S; Sugiyama T
Int J Cancer; 1987 Oct; 40(4):474-8. PubMed ID: 2889677
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of the c-Ha-ras-1 proto-oncogene in sporadic and familial breast cancer.
Barkardóttir RB; Jóhannsson OT; Arason A; Gudnason V; Egilsson V
Int J Cancer; 1989 Aug; 44(2):251-5. PubMed ID: 2668204
[TBL] [Abstract][Full Text] [Related]
16. c-Ha-ras-1 alleles in bladder cancer, Wilms' tumour and malignant melanoma.
Hayward NK; Keegan R; Nancarrow DJ; Little MH; Smith PJ; Gardiner RA; Seymour GJ; Kidson C; Lavin MF
Hum Genet; 1988 Feb; 78(2):115-20. PubMed ID: 2892780
[TBL] [Abstract][Full Text] [Related]
17. Distribution of Ha-ras alleles in patients with colorectal cancer and Crohn's disease.
Klingel R; Mittelstaedt P; Dippold WG; Meyer zum Büschenfelde KH
Gut; 1991 Dec; 32(12):1508-13. PubMed ID: 1685466
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of the human Ha-ras oncogene locus in chronic lymphocytic and chronic myelogenous leukemia.
Knauf WU; Ho AD
Hematol Oncol; 1991; 9(3):157-62. PubMed ID: 1682229
[TBL] [Abstract][Full Text] [Related]
19. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population.
Hirvonen A; Husgafvel-Pursiainen K; Karjalainen A; Anttila S; Vainio H
Cancer Epidemiol Biomarkers Prev; 1992; 1(6):485-9. PubMed ID: 1284589
[TBL] [Abstract][Full Text] [Related]
20. Association of a 12.5-kilobase allele of the MspI restriction fragment length polymorphism of the C6 gene in patients with total deficiency of the sixth component of complement.
Potter PC; Warburton C; Würzner R; Orren A; Di Scipio R
Exp Clin Immunogenet; 1993; 10(1):38-44. PubMed ID: 7691111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
